Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 647

1.

Metabolic Syndrome as a Predictor of Adrenal Functional Status: A Discriminant Multivariate Analysis Versus Logistic Regression Analysis.

Tsentidis C, Bampilis A, Ntova V, Fragkos D, Panos C, Limniati C, Kassi G.

Horm Metab Res. 2018 Nov 7. doi: 10.1055/a-0754-6464. [Epub ahead of print]

PMID:
30406628
2.

No association between cardiometabolic risk and neural reactivity to acute psychosocial stress.

Lederbogen F, Ulshöfer E, Peifer A, Fehlner P, Bilek E, Streit F, Deuschle M, Tost H, Meyer-Lindenberg A.

Neuroimage Clin. 2018 Oct 22;20:1115-1122. doi: 10.1016/j.nicl.2018.10.018. [Epub ahead of print]

3.

Adipocytokines in Non-functional Adrenal Incidentalomas and Relation with Insulin Resistance Parameters.

Akkus G, Evran M, Sert M, Tetiker T.

Endocr Metab Immune Disord Drug Targets. 2018 Oct 9. doi: 10.2174/1871530318666181009112042. [Epub ahead of print]

PMID:
30306882
4.

Serum Amyloid P and Endocrine Markers in a Cohort of Obese Children.

Anwer M, Iqbal MJ.

Indian J Endocrinol Metab. 2018 Sep-Oct;22(5):683-688. doi: 10.4103/ijem.IJEM_66_18.

5.

"The Adrenal Gland: Central Relay in Health and Disease - Current Challenges and Perspectives 2018" - Cushing's Disease.

Stalla GK, Ciato D, Dimopoulou C.

Exp Clin Endocrinol Diabetes. 2018 Aug 21. doi: 10.1055/a-0664-7632. [Epub ahead of print]

PMID:
30130808
6.

Glycometabolic Alterations in Secondary Adrenal Insufficiency: Does Replacement Therapy Play a Role?

Graziadio C, Hasenmajer V, Venneri MA, Gianfrilli D, Isidori AM, Sbardella E.

Front Endocrinol (Lausanne). 2018 Aug 3;9:434. doi: 10.3389/fendo.2018.00434. eCollection 2018. Review.

7.

A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, INU-101.

Hong SP, Han D, Chang KH, Ahn SK.

Eur J Pharmacol. 2018 Sep 15;835:169-178. doi: 10.1016/j.ejphar.2018.08.005. Epub 2018 Aug 8.

PMID:
30096297
8.

Thiazolo[3,2-a]pyrimidin-5-one derivatives as a novel class of 11β-hydroxysteroid dehydrogenase inhibitors.

Studzińska R, Kupczyk D, Płazińska A, Kołodziejska R, Kosmalski T, Modzelewska-Banachiewicz B.

Bioorg Chem. 2018 Dec;81:21-26. doi: 10.1016/j.bioorg.2018.07.033. Epub 2018 Aug 1.

PMID:
30086417
9.

Nonfunctioning adrenal incidentaloma: A novel predictive factor for metabolic syndrome.

Ribeiro Cavalari EM, de Paula MP, Arruda M, Carraro N, Martins A, de Souza K, Coelho MC, de Oliveira E Silva de Morais NA, Moraes AB, Vieira Neto L.

Clin Endocrinol (Oxf). 2018 Nov;89(5):586-595. doi: 10.1111/cen.13822. Epub 2018 Aug 21.

PMID:
30044007
10.

Salivary Cortisol Does Not Correlate with Metabolic Syndrome Markers or Subjective Stress in Overweight Children.

Strait RB, Slattery MJ, Carrel AL, Eickhoff J, Allen DB.

J Child Obes. 2018;3(2). pii: 8. doi: 10.21767/2572-5394.100048. Epub 2018 Apr 18.

11.

Could Lipid Profile be Used as a Marker of Autonomous Cortisol Secretion in Patients with Adrenal Incidentalomas?

Mintziori G, Georgiou T, Anagnostis P, Adamidou F, Efstathiadou Z, Panagiotou A, Kita M.

Horm Metab Res. 2018 Jul;50(7):551-555. doi: 10.1055/a-0630-1397. Epub 2018 Jul 10.

PMID:
29991085
12.

Biological rhythms, chronodisruption and chrono-enhancement: The role of physical activity as synchronizer in correcting steroids circadian rhythm in metabolic dysfunctions and cancer.

Vitale JA, Lombardi G, Weydahl A, Banfi G.

Chronobiol Int. 2018 Sep;35(9):1185-1197. doi: 10.1080/07420528.2018.1475395. Epub 2018 Jun 28.

PMID:
29953265
13.

SALIVARY CORTISOL AND METABOLIC SYNDROME COMPONENT'S ASSOCIATION.

Garbellotto GI, Reis FJ, Feoli AMP, Piovesan CH, Gustavo ADS, Oliveira MDS, Macagnan FE, Ferreira CAS, Bauer ME, Wietzycoski CR.

Arq Bras Cir Dig. 2018 Jun 21;31(1):e1351. doi: 10.1590/0102-672020180001e1351. English, Portuguese.

14.

Metabolic Syndrome in Hypopituitarism.

Miljić D, Popovic V.

Front Horm Res. 2018;49:1-19. doi: 10.1159/000485997. Epub 2018 Apr 5.

PMID:
29895033
15.

Metabolic Syndrome in Cushing's Syndrome Patients.

Ferraù F, Korbonits M.

Front Horm Res. 2018;49:85-103. doi: 10.1159/000486002. Epub 2018 Apr 5.

PMID:
29894989
16.

Neuroendocrine Regulation of Air Pollution Health Effects: Emerging Insights.

Snow SJ, Henriquez AR, Costa DL, Kodavanti UP.

Toxicol Sci. 2018 Jul 1;164(1):9-20. doi: 10.1093/toxsci/kfy129.

PMID:
29846720
17.

Alterations of Cortisol Metabolism in Human Disorders.

White PC.

Horm Res Paediatr. 2018;89(5):320-330. doi: 10.1159/000485508. Epub 2018 May 29. Review.

PMID:
29843121
18.

Design and synthesis of functionalized piperazin-1yl-(E)-stilbenes as inhibitors of 17α-hydroxylase-C17,20-lyase (Cyp17).

Blass BE, Iyer P, Abou-Gharbia M, Childers WE, Gordon JC, Ramanjulu M, Morton G, Arumugam P, Boruwa J, Ellingboe J, Mitra S, Reddy Nimmareddy R, Paliwal S, Rajasekhar J, Shivakumar S, Srivastava P, Tangirala RS, Venkataramanaiah K, Bobbala R, Yanamandra M, Krishnakanth Reddy L.

Bioorg Med Chem Lett. 2018 Jul 15;28(13):2270-2274. doi: 10.1016/j.bmcl.2018.05.040. Epub 2018 May 22.

PMID:
29803730
19.

Basal cortisol levels and metabolic syndrome: A systematic review and meta-analysis of observational studies.

Garcez A, Leite HM, Weiderpass E, Paniz VMV, Watte G, Canuto R, Olinto MTA.

Psychoneuroendocrinology. 2018 Sep;95:50-62. doi: 10.1016/j.psyneuen.2018.05.023. Epub 2018 May 17. Review.

PMID:
29800780
20.

Insulin Resistance is Related to Psychiatric Disorders Among Obese Children.

Özalp Kızılay D, Yalın Sapmaz Ş, Şen S, Özkan Y, Ersoy B.

J Clin Res Pediatr Endocrinol. 2018 May 23. doi: 10.4274/jcrpe.0055. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center